Table 3

GRADE evaluation of the quality of evidence of reviews included in this study

StudyPatientsInterventionComparisonOutcomeNo. of patients/studiesEffect RR/OR/MD (95% CI)Absolute effect (95%)QualityAMSTAR score
Baoxia Chang 201423Simple obesityElectroacupuncture combined with auricular point plasterElectroacupunctureRate of effectiveness397 (5)RR=1.18 (1.07 to 1.25)132 more per 1000 (from 51 more to 183 more)Moderate (1a, 1c)7.5
Wangqin Shen 201013PhlebitisRuyijinhuangsanMagnesium sulfate by wet compressionRate of effectiveness327 (6)RR=1.32 (1.26 to 1.34)236 more per 1000 (from 191 more to 250)Very low (1a, 1b, 1c, 3a, 4a, 5a)4.5
Hongying Pu 201115Pressure ulcersMoist exposed burn ointmentSkin disinfection solution or antibiotic ointmentCure rate432 (11)RR=2.22 (2.07 to 2.33)468 more per 1000 (from 410 more to 510 more)Very low (1a, 1b, 1c, 2, 3a, 5a, 5b)6
Time of cure261 (5)MD=6.93 (7.7 to 6.15)MD=6.93 lower (7.7 to 6.15 lower)Very low (1a, 1b, 1c, 3a, 4a, 5a, 5b)6
Xuan Zhou 201116Postoperative patientsAcupressure wristbandsPlacebo wristbandIncidence of nausea1117 (9)RR=0.85 (0.72 to 1)46 fewer per 1000 (from 86 fewer to 0 more)Moderate (4b,5a)5.5
Incidence of vomiting1117 (9)RR=0.44 (0.31 to 0.62)107 fewer per 1000 (from 72 fewer to 131 fewer)Moderate (4a, 5a)5.5
Xiaoli Wu 201231 17Diabetic foot ulcersFoot bath therapy or foot massage with traditional Chinese medicineHot foot bathEffective rate845 (8)RR=1.44 (1.4 to 1.46)293 more per 1000 (from 267 more to 307 more)Low (1a,1b, 2, 5a,5b)6.5
Xilan Zheng 201218Postoperative patientsTraditional Chinese medicine for elimination of necrotic tissuesSkin disinfection solution or antibiotic ointmentCure rate551 (9)RR=1.89 (1.65 to 2.17)401 more per 1000 (from 293 more to 527 more)Low (1a, 1b, 1c, 2)5.5
Cure time355 (6)MD=9.33 (9.9 to 8.76)MD=9.33 lower (9.9 to 8.76 lower)Low (1a, 1b, 1c, 2)5.5
Na Li 201114PhlebitisExternal application with aloe veraMagnesium sulfate by wet compressionEffective rate712 (7)RR=1.25 (1.2 to 1.27)192 more per 1000 (from 153 to 206)Low (1a, 1b, 1c, 5a)6
Jiaqi Xu 201320Pressure ulcerResina draconisSkin disinfection solution or antibiotic ointmentEffective rate573 (13)RR=1.2 (1.13 to 1.28)162 more per 1000 (from 105 more to 227 more)Moderate (1a, 1b, 1c)8
Yuan Zhao 201321Elderly individualsTai ChiRegular sport or physical therapyRate of falls1443 (4)RR=0.82 (0.73 to 0.92)83 fewer per 1000 (from 37 fewer to 124 fewer)Moderate (3a)6.5
BBS345 (2)MD=2.45 (1.47 to 0.43)MD=2.45 higher (1.47 to 3.43 higher)Low (3a, 3b, 4a)6.5
Xiaoyan Wen 201319Viral hepatitisChinese herbal retention enema and comprehensive treatmentComprehensive treatmentEffective rate: after 2 weeks from cure time260 (4)RR=1.51 (1.3 to 1.67)259 more per 1000 (from 152 more to 340 more)Low (1a, 1b, 1c, 4a)8
Effective rate: after 4 weeks from cure time333 (5)OR=4.17 (2.37 to 7.32)250 more per 1000 (from 173 more to 300 more)Low (1a, 1b, 1c, 4a)8
Pingping Zheng 201322Elders living in homeTai ChiRegular sport or physical therapy or blank controlRate of fall2624 (9)RR=0.85 (0.79 to 0.92)73 fewer per 1000 (from 39 fewer to 102 fewer)Moderate (2)6
Guohao Wang 201430ConstipationAcupoint massage and ventral massageRoutine nursingRate of effectiveness2170 (19)RR=1.93 (1.86 to 2)396 more per 1000 (from 366 more to 426 more)Low (1a, 1c, 2, 3a)7
Jihuan Feng 201425Patients with cancer receiving adjuvant chemotherapyAcupoint massageRoutine nursingDuration of chemotherapy-induced nausea942 (7)MD=1.52 (1.77 to 1.26)MD=1.52 lower (1.77 to 1.26 lower)Low (1a, 1b, 1c, 1e, 2)7
Frequency of chemotherapy-induced nausea942 (7)MD=1.08 (1.32 to 0.83)MD=1.08 lower (1.32 to 0.83 lower)Low (1a, 1b, 1c, 1e, 2)7
Severity of chemotherapy-induced nausea942 (7)MD=1.17(1.37 to 0.96)MD=1.17 lower (1.37 to 0.96 lower)Low (1a, 1b, 1c, 1e, 2)7
Shaoxia Meng 201428Diabetics with peripheral neuropathyFoot massage or massage in foot reflection area or acupoint massage for lower limbsRoutine nursingRate of effectiveness323 (5)RR=1.47 (1.29 to 1.68)297 more per 1000 (from 183 more to 430 more)Low (1a, 1c, 3a, 4a, 5a)6.5
Xijuan Cui 201424Postoperative patients with abdominal operation*Acupoint massage for Zusanli, Zusanli point acupuncture, Chinese medicine application at the Zusanli pointRoutine nursingFirst aerofluxus time: subgroup for Zusanli point acupuncture*317 (3)MD=14.52 (15.49 to 13.54)MD=14.52 lower (15.49 to 13.54 lower)Low (1a, 1b, 1c, 1f, 2,4a, 5a)8
Subgroup for acupoint massage for Zusanli*326 (4)MD=22.7 (25.67 to 19.73)MD=22.7 lower (25.67 to 19.73 lower)Low (1a, 1b, 1c, 1f, 2, 4a, 5a)8
Subgroup for Chinese medicine application at the Zusanli point*1048 (6)MD=18.25 (18.6 to 17.9)MD=18.25 lower (18.6 to 17.9 lower)Moderate (1a, 1b, 1c, 1f, 2, 5a)8
Zhong Sun 201429Patients with primary dysmenorrhoeaUmbilical compression with Chinese herbsAnalgesic drugRate of effectiveness496 (5)RR=1.93 (1.45 to 2.57)214 more per 1000 (from 104 more to 362 more)Very low (1a, 1b, 2, 3a, 4a)5
Ye Li 201426Women in labourAcupoint massage for Sanyinjiao, Hegu, Zhiyin, Taichong, Ashi, Shenshu and othersBlank controlRate of effectiveness766 (6)RR=1.64 (1.56 to 1.7)347 more per 1000 (from 304 more to 380 more)Low (1a, 1b, 1c, 2, 5a, 5b)7
Yuanyuan Yang 201531Insomnia*Auricular point therapyAcupuncture or drug therapyEffective rate after 2 weeks from cure time606 (3)RR=1.28 (1.2 to 1.37)212 more per 1000 (from 152 more to 281 more)Low (1a, 1b, 1c, 2)7
Auricular point therapyAcupuncture or drug therapyEffective rate after 4 weeks from cure time333 (4)RR=1.25 (1.13 to 1.37)186 more per 1000 (from 97 more to 276 more)Low (1a, 1b, 1c, 4a)7
Yue Ma 201427IleusEnema and gastrointestinal intubation with traditional Chinese medicineBlank controlRate of effectiveness2821 (27)RR=1.24 (1.2 to 1.29179 more per 1000 (from 149 more to 216 more)Low (1a, 1b, 1c, 1f, 5b)8
Weiwei Wu 201632Elderly individualTraditional Chinese exerciseOther intervention or regular nursingSubgroup for PSQI for Tai Chi554 (8)MD=−2.15 (−4.61 to 0.30)MD=2.15 lower (4.61 lower to 0.3 higher)Low (1a, 1b, 1c, 2, 5b)8
Subgroup for PSOI for Qi Gong55 (2)MD=−4.29 (−5.29 to −3.29)MD=4.29 lower (5.29 lower to 3.29 lower)Low (1a, 1b, 1c, 4a, 5b)8
  • Risk of bias: (1a) failed to conceal allocation; (1b) no blinding used; (1c) incomplete reporting of random sequence generation in most studies included; (1d) use of unvalidated outcome measure; (1e) loss to follow-up and failure to adhere to the intention-to-treat principle; (1f) non-randomised controlled trial was included.

  • Inconsistency: (2) unexplained heterogeneity or inconsistency of results.

  • Indirectness: (3a) differences in therapeutic methods between intervention and control groups; (3b) surrogate outcome.

  • Imprecision: (4a) optimal information size criterion was not met; (4b) wide confidence internals.

  • Publication bias; (5a) flaws in literature search; (5b) funnel plot asymmetry.

  • *Subgroup.

  • AMSTAR, Assessment of Multiple Systematic Reviews; GRADE, Grading of Recommendations Assessment, Development and Evaluation; PSOI, psoriasis; PSQI, Pittsburgh Sleep Quality Index; RR, risk ratio; MD, mean difference.